Cargando…

Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function

BACKGROUND: Duchenne muscular dystrophy (DMD), an X-linked disorder affects approximately 1 in 5000 males, is universally associated with heart disease. We previously identified myocardial disease by late gadolinium enhancement (LGE) in DMD subjects at various stages of disease, but the true prevale...

Descripción completa

Detalles Bibliográficos
Autores principales: Hor, Kan N, Taylor, Michael D, Al-Khalidi, Hussein R, Cripe, Linda H, Raman, Subha V, Jefferies, John L, O’Donnell, Robert, Benson, D Woodrow, Mazur, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896985/
https://www.ncbi.nlm.nih.gov/pubmed/24359596
http://dx.doi.org/10.1186/1532-429X-15-107
_version_ 1782300167134773248
author Hor, Kan N
Taylor, Michael D
Al-Khalidi, Hussein R
Cripe, Linda H
Raman, Subha V
Jefferies, John L
O’Donnell, Robert
Benson, D Woodrow
Mazur, Wojciech
author_facet Hor, Kan N
Taylor, Michael D
Al-Khalidi, Hussein R
Cripe, Linda H
Raman, Subha V
Jefferies, John L
O’Donnell, Robert
Benson, D Woodrow
Mazur, Wojciech
author_sort Hor, Kan N
collection PubMed
description BACKGROUND: Duchenne muscular dystrophy (DMD), an X-linked disorder affects approximately 1 in 5000 males, is universally associated with heart disease. We previously identified myocardial disease by late gadolinium enhancement (LGE) in DMD subjects at various stages of disease, but the true prevalence is unclear. Cardiovascular magnetic resonance (CMR) is well established for both assessment of ventricular function and myocardial fibrosis by LGE. We sought to establish i) prevalence and distribution of LGE in a large DMD population and ii) relationship among LGE, age, LVEF by CMR and current living status. METHODS: Current living status, demographic and CMR data including ventricular volumes, LVEF and LGE from 314 DMD patients undergoing evaluation at a single large tertiary referral center were analyzed. RESULTS: 113 of 314 (36%) of DMD subjects showed LGE positivity with prevalence increasing from 17% of patients <10 years to 34% of those aged 10–15 years and 59% of those >15 years-old. Patients with LVEF ≥55% were LGE positive in 30% of cases; this increased to 84% for LVEF <55%. LGE was more prevalent in the free wall (531/1243, 42.7%) vs. septal segments (30/565, 5.3%). Patients with septal involvement were significantly older and had lower LVEF than those with isolated free wall LGE. Ten percent (11/113) patients who had LGE died 10.8 months after CMR. Only one patient from the LGE negative group died. Patients who died had higher heart rate, larger left ventricular volume and mass, greater number of positive LGE segment and increase incident of septal LGE compared to those who remained alive. CONCLUSION: In DMD patients, LGE occurs early, is progressive and increases with both age and decreasing LVEF. Segmentally, the incidence of the number of positive LGE segments increase with age and lower LVEF. Older patients and those who died during the study period had more septal LGE involvement. The current studies suggest that the time course and distribution of LGE-positivity may be an important clinical biomarker to aid in the management of DMD-associated cardiac disease.
format Online
Article
Text
id pubmed-3896985
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38969852014-01-22 Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function Hor, Kan N Taylor, Michael D Al-Khalidi, Hussein R Cripe, Linda H Raman, Subha V Jefferies, John L O’Donnell, Robert Benson, D Woodrow Mazur, Wojciech J Cardiovasc Magn Reson Research BACKGROUND: Duchenne muscular dystrophy (DMD), an X-linked disorder affects approximately 1 in 5000 males, is universally associated with heart disease. We previously identified myocardial disease by late gadolinium enhancement (LGE) in DMD subjects at various stages of disease, but the true prevalence is unclear. Cardiovascular magnetic resonance (CMR) is well established for both assessment of ventricular function and myocardial fibrosis by LGE. We sought to establish i) prevalence and distribution of LGE in a large DMD population and ii) relationship among LGE, age, LVEF by CMR and current living status. METHODS: Current living status, demographic and CMR data including ventricular volumes, LVEF and LGE from 314 DMD patients undergoing evaluation at a single large tertiary referral center were analyzed. RESULTS: 113 of 314 (36%) of DMD subjects showed LGE positivity with prevalence increasing from 17% of patients <10 years to 34% of those aged 10–15 years and 59% of those >15 years-old. Patients with LVEF ≥55% were LGE positive in 30% of cases; this increased to 84% for LVEF <55%. LGE was more prevalent in the free wall (531/1243, 42.7%) vs. septal segments (30/565, 5.3%). Patients with septal involvement were significantly older and had lower LVEF than those with isolated free wall LGE. Ten percent (11/113) patients who had LGE died 10.8 months after CMR. Only one patient from the LGE negative group died. Patients who died had higher heart rate, larger left ventricular volume and mass, greater number of positive LGE segment and increase incident of septal LGE compared to those who remained alive. CONCLUSION: In DMD patients, LGE occurs early, is progressive and increases with both age and decreasing LVEF. Segmentally, the incidence of the number of positive LGE segments increase with age and lower LVEF. Older patients and those who died during the study period had more septal LGE involvement. The current studies suggest that the time course and distribution of LGE-positivity may be an important clinical biomarker to aid in the management of DMD-associated cardiac disease. BioMed Central 2013-12-21 /pmc/articles/PMC3896985/ /pubmed/24359596 http://dx.doi.org/10.1186/1532-429X-15-107 Text en Copyright © 2013 Hor et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hor, Kan N
Taylor, Michael D
Al-Khalidi, Hussein R
Cripe, Linda H
Raman, Subha V
Jefferies, John L
O’Donnell, Robert
Benson, D Woodrow
Mazur, Wojciech
Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
title Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
title_full Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
title_fullStr Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
title_full_unstemmed Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
title_short Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
title_sort prevalence and distribution of late gadolinium enhancement in a large population of patients with duchenne muscular dystrophy: effect of age and left ventricular systolic function
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896985/
https://www.ncbi.nlm.nih.gov/pubmed/24359596
http://dx.doi.org/10.1186/1532-429X-15-107
work_keys_str_mv AT horkann prevalenceanddistributionoflategadoliniumenhancementinalargepopulationofpatientswithduchennemusculardystrophyeffectofageandleftventricularsystolicfunction
AT taylormichaeld prevalenceanddistributionoflategadoliniumenhancementinalargepopulationofpatientswithduchennemusculardystrophyeffectofageandleftventricularsystolicfunction
AT alkhalidihusseinr prevalenceanddistributionoflategadoliniumenhancementinalargepopulationofpatientswithduchennemusculardystrophyeffectofageandleftventricularsystolicfunction
AT cripelindah prevalenceanddistributionoflategadoliniumenhancementinalargepopulationofpatientswithduchennemusculardystrophyeffectofageandleftventricularsystolicfunction
AT ramansubhav prevalenceanddistributionoflategadoliniumenhancementinalargepopulationofpatientswithduchennemusculardystrophyeffectofageandleftventricularsystolicfunction
AT jefferiesjohnl prevalenceanddistributionoflategadoliniumenhancementinalargepopulationofpatientswithduchennemusculardystrophyeffectofageandleftventricularsystolicfunction
AT odonnellrobert prevalenceanddistributionoflategadoliniumenhancementinalargepopulationofpatientswithduchennemusculardystrophyeffectofageandleftventricularsystolicfunction
AT bensondwoodrow prevalenceanddistributionoflategadoliniumenhancementinalargepopulationofpatientswithduchennemusculardystrophyeffectofageandleftventricularsystolicfunction
AT mazurwojciech prevalenceanddistributionoflategadoliniumenhancementinalargepopulationofpatientswithduchennemusculardystrophyeffectofageandleftventricularsystolicfunction